The Hoya5h
THE REPRO RUNDOWN | Understanding Urinary Tract Infections: Why Do We Get UTIs?
As I perused the latest edition of Georgetown’s leading publication — the Stall Seat Journal — I was pleased to see a brief ...
The American Journal of Managed Care14h
Patient Burden Associated With Uncomplicated UTIs
Panelists discuss how patients with recurrent urinary tract infections (UTIs) describe significant burdens including constant anxiety about symptom onset, disruption to work and social life, financial ...
Everyday Health1d
FDA Approves the First New UTI Antibiotic in Nearly 30 Years
This antibiotic is the first new FDA-approved medication for urinary tract infections in decades, and meets the need for new ...
Science-Based Medicine1d
Cranberry Juice, Revisited
A new review suggests that cranberries may in fact be effective at preventing urinary tract infections.
WHDH 7News2d
Millions of women get painful UTIs that keep coming back. A new kind of antibiotic may help break the cycle
The US Food and Drug Administration has approved a new type of antibiotic to treat urinary tract infections. The pill, ...
FDA approves first new UTI drug in decades
The Food and Drug Administration (FDA) has approved a new drug for treating urinary tract infections, the first such drug ...
Al Día News2d
After 30 Years, a New Antibiotic for Urinary Tract Infections Arrives
The FDA has approved the drug for use in women and girls over the age of 12 who suffer from uncomplicated urinary tract ...
Scripps News2d
FDA approves first new antibiotic treatment for UTIs in decades
A new antibiotic has been approved to treat urinary tract infections by the Food and Drug Administration for the first time ...
Here’s what to know about Blujepa, the new FDA-approved UTI treatment heading to market this year
GSK's pill, the first oral antibiotic for urinary tract infections in almost 30 years, comes as bacteria are increasingly ...
FDA approves new UTI antibiotic that may help patients with recurring infections
FDA approves new UTI antibiotic that may help patients with recurring infections - A commercial launch of the antibiotic in ...
MPR2d
FDA Approves Blujepa for Uncomplicated UTI in Female Patients
Gepotidacin is an oral, first-in-class triazaacenaphthylene antibiotic that inhibits bacterial DNA replication by blocking 2 different type II topoisomerase enzymes.